“I was impressed to learn about the different ways the software is being used in other organizations and I’m excited to take this information back and share with my colleagues”

Dr David Snead, Coventry University Hospital

“The molecular pathology tissue assessment module developed in collaboration with PathXL will help drive high standards and good quality molecular pathology testing across the country.

This will initially be part of the 100,000 Genomes project and will then be developed to all laboratories providing a clinical molecular pathology testing service.”

Dr Sandi Deans, Scheme Director UKNEQAS

“Microscopy teaching at the University of Copenhagen is carried out entirely online using PathXL – known as the VIRMIK (Virtual Microscopy) service.

We noticed a rise in the number of students utilizing tablet devices over laptops primarily due to their convenient size and lower cost. Given the success of VIRMIK here at UCPH it was important to deliver this leading software solution on the latest tablet devices.

We worked closely with PathXL to ensure we delivered a solution for a wide range of devices and operating systems to best serve our large Medical, Veterinary and Science student population using VIRMIK.”

Niels Werner Mortensen, University of Copenhagen

“PathXL was chosen as the company was capable of providing a technologically advanced virtual microscopy platform that could be optimally integrated onto the ECP e-learning portal under development.

An additional element has been the mutually profitable working relationship that has developed over time through the Europals project and in which PathXL has proven to be capable of responding efficiently and effectively to their client’s needs.

PathXL will allow the ESP to continue to provide the ECP slide seminars at high quality online, and to optimally exploit virtual microscopy as an educational tool and proficiency testing instrument.”

Fred Bosman, ESP

“We wanted a new and effective way to teach our students that would enable us to produce up-to-date, high quality learning material.

PathXL provide this in the form of a very easy to use solution that helps us build course content, tests and also create a virtual slide library. A great bonus is that course material is accessible at any time from any location and we know our students especially appreciate this.

PathXL was incredibly easy to set up and the hosting service means we didn’t need to worry about managing an internal IT infrastructure.”

Mogens Vyberg, Professor of Clinical Pathology at the University of Aalborg

“Corneal disease is a leading cause of blindness worldwide and affects individuals of both genders and of all age groups.

The PathXL Sample Tracker system is supporting the collection of clinical data from hundreds of corneal transplant recipients at 5 leading centres across Europe for the VISICORT project.

In addition to clinical data entry, the system allows our front-line researchers to log and track thousands of biological specimens associated with this patient cohort. As the project evolves, our technology partners and bio-informaticians will be able to harness the system to link gene and protein expression profiles to prospectively acquired clinical data in a secure, anonymised electronic environment.

By having a central resource for the collection, management and archiving, as well as a centralised support centre offered by PathXL we can focus on the science.”

Prof. Matthew Griffin directs the VISICORT dissemination programme

“I welcome the development of this new TissueMark technology which will bring new levels of efficiency and accuracy to tissue annotation, freeing pathology professionals worldwide to focus their time and expertise on their most important work, the accurate and timely diagnosis of tumours and other disorders.”

Dr Scott Binder 
Senior Vice Chair and Director of Pathology Clinical Services at the Department of Pathology & Laboratory Medicine at the University of California at Los Angeles (UCLA)

“Using PathXL’s platform has ensured we are time and resource efficient, allowing tissue selection for Human Genome sequencing to be made rapidly and with confidence”

This is a rapid and robust approach to obtaining reliable diagnoses on frequently difficult tissues. The consequence is a high level of confidence in the correct evaluation of those tissues subsequently extracted and submitted for Human Genome analysis, and in the data obtained thereafter.”

Professor Chris Foster, International Cancer Genome Consortium

“The Halo platform has given us the ability to jump straight into running algorithms across our whole slide images and TMAs.

The initial training was excellent ensuring a minimal learning curve and the ongoing support has helped greatly. We are excited about accelerating our research with such a powerful platform.”

Agnieszka Krzyzanowska from Anders Bjartell’s laboratory Lund, running projects involving tissue biomarkers in prostate cancer – Lund University, Sweden